Marc E. Rothenberg, MD, PhD discusses the exciting findings regarding the role of proteases and protease inhibitors in a food allergic disease of the esophagitis, eosinophilic esophagitis (EoE), and how this knowledge and an FDA-approved drug may lead to new treatment.
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis
